secwatch / observer
8-K filed December 16, 2022, 6:59 PM ET ticker HEPA CIK 0001583771
other material confidence high sentiment neutral materiality 0.50

Hepion shareholders approve reverse stock split; Board to set ratio 1:2 to 1:20

Hepion Pharmaceuticals, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Hepion Pharmaceuticals, Inc. shareholders approved Adoption and approval of an amendment to the Certificate of Incorporation to effect a reverse stock split of common stock at a ratio ranging from 1:2 to 1:20, with the exact ratio determined by the Board at the 2022-12-15 meeting.

Proposal
reverse split
Outcome
passed
Meeting
2022-12-15
Exact text from the filing
The proposal to adopt and approve an amendment to the Charter to effect a reverse stock split of the Company’s issued and outstanding shares of Common Stock, at a specific ratio, ranging from one-for-two (1:2) to one-for-twenty (1:20), at any time prior to the one-year anniversary date of the Special Meeting, with the exact ratio to be determined by the Board was approved by a majority of the voting power of the outstanding shares of Common Stock, Series A Preferred Stock Series F Preferred Stock and Series G Preferred Stock entitled to vote on the proposal, based upon the following votes: Votes For Votes Against Votes Abstained Broker Non-Vote 6,757,528,739 3,262,017,173 38,856,945 0
View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Hepion Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-22-127475
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.